John L. Knopf, CEO and President at ACCELERON PHARMA INC (XLRN), sold 19,000 shares at $28.51 ($542K) on 2015-08-10, disclosed to the SEC on 2015-08-12.
Scheduled sale ($542k) by CEO and President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.51 | 18,500 | $527K | 97.3% |
| 2 | $29.22 | 500 | $15K | 2.7% |
| Total | $28.53 avg | 19,000 | $542K | 100% |
| Filing → |
| XLRN | SELL | 2016-05-20 | $3.3M | — | Filing → |
| XLRN | SELL | 2015-10-09 | $463K | — | Filing → |
| XLRN | SELL | 2015-09-10 | $574K | — | Filing → |